🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objectives of this study are to evaluate the safety and tolerab...
Status
Completed
Location
Samsung Medical Center
Start Date
2010-03
Trial ID
NCT01199055
Treatments Being Tested
This is a phase III, randomized, double-blinded, multicenter clinical study...
Status
Completed
Location
Shanghai Chest Hospital
Start Date
2018-12-20
Trial ID
NCT03866993
Treatments Being Tested
One-arm, multi-center clinical trial of paclitaxel (albumin-binding) combin...
Status
Unknown
Location
Multiple Locations
Start Date
2019-11
Trial ID
NCT04148885
Treatments Being Tested
This study is a Phase 3, global, multi-center, open-label study of patients...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2006-08
Trial ID
NCT00363415
Treatments Being Tested
Anlotinib which has shown an affirmatory efficacy in ALTER0303 controlled t...
Status
Unknown
Location
Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology,
Start Date
2019-03-01
Trial ID
NCT03799601
Treatments Being Tested
The purpose of this study is to assess whether patients who are likely to f...
Status
Unknown
Location
BC Cancer Agency
Start Date
2006-08
Trial ID
NCT00324467
The goal of this clinical trial is to investigate the efficacy, safety and ...
Status
Unknown
Location
Shanghai Chest Hospital
Start Date
2023-07-04
Trial ID
NCT06424821
Treatments Being Tested
The purpose of this clinical trial is to find out whether or not the combin...
Status
Completed
Location
Northwest Alabama Cancer Center
Start Date
2006-11
Trial ID
NCT00347412
Treatments Being Tested
The aim of this feasibility study is to determine the therapeutic potential...
Status
Terminated
Location
University Hospital Pisa
Start Date
2010-05
Trial ID
NCT01124812
The primary purpose of this study is to determine the maximum tolerated dos...
Status
Terminated
Location
University of Texas, MD Anderson Cancer Center
Start Date
2006-11-01
Trial ID
NCT00407407
Treatments Being Tested